Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heron Therapeutics (NQ: HRTX )

3.450 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.450
Bid (Size) 3.100 (9)
Ask (Size) 3.520 (11)
Prev. Close 3.450
Today's Range 3.450 - 3.450
52wk Range 0.5000 - 3.585
Shares Outstanding 140,759,276
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 3 Health Care Stocks That May Crash In May
Via Benzinga
HRTX Stock Earnings: Heron Therapeutics Beats EPS, Beats Revenue for Q1 2024
HRTX stock results show that Heron Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+82.54%
+82.54%
1 Month
+30.19%
+30.19%
3 Month
+32.69%
+32.69%
6 Month
+150.00%
+150.00%
1 Year
+163.36%
+163.36%

More News

Read More
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Heron Therapeutics Inc. (NASDAQ: HRTX) Near the Top of Equities by Percentage Gain on 4/23
Via Investor Brand Network
Heron Therapeutics: Q4 Earnings Insights
Via Benzinga
Preview: Heron Therapeutics's Earnings
Via Benzinga
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod
Via Benzinga
Exposures Product Safety
Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For March 12, 2024
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in January
Via InvestorPlace
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
Via InvestorPlace
Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Is Pain Treatment Focused Heron Therapeutics Stock Trading Higher Today?
Via Benzinga
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Rises Over 100 Points; Target Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.